UreaAide™ Ureatabs deliver pharmaceutical-grade USP urea in tablet form for clinical management of syndrome of inappropriate antidiuretic hormone (SIADH)-induced hyponatremia. The osmotically active urea molecule facilitates aquaporin-mediated free water excretion, restoring serum sodium concentration without electrolyte depletion—a critical distinction from sodium-based interventions. The tablet formulation eliminates palatability barriers associated with liquid or powder preparations, enhancing patient compliance in long-term osmotic therapy. Each dose provides standardized urea quantity for precise dosing titration under medical supervision. Classified as a medical food, this preparation supports evidence-based management of chronic hyponatremic conditions requiring sustained osmotic diuresis.